AMSTERDAM, the Netherlands—It’s no surprise that injectable semaglutide leads to significant weight loss among obese heart failure patients with preserved ejection fraction (HFpEF), but as the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results